Y.H. Park
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 51
- HER2/EGFR in Cancer Research 25
- Cancer Treatment and Pharmacology 24
- Cancer Immunotherapy and Biomarkers 10
- PARP inhibition in cancer therapy 7
-
- Advanced Breast Cancer Therapies 23
- Lung Cancer Treatments and Mutations 6
- Brain Metastases and Treatment 5
- Co-authors
- Javier Cortés (12 shared papers)Rebecca Dent (8 shared papers)Vassiliki Karantza (6 shared papers)Konstantinos Tryfonidis (5 shared papers)Joohyuk Sohn (11 shared papers)Theodoros Foukakis (4 shared papers)Sherko Küemmel (3 shared papers)Peter Schmid (2 shared papers)
- Journals
- Annals of Oncology (44 papers)ESMO Open (7 papers)Journal of the American Chemical Society (2 papers)Angewandte Chemie International Edition (2 papers)Laryngoscope Investigative Otolaryngology (1 paper)
- Partner nations
- South KoreaUnited StatesUnited Kingdom
In The Last Decade
Y.H. Park
59 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 1.1k
- Cancer Research 295
- Immunology 253
- Reproductive Medicine 101
- Pulmonary and Respiratory Medicine 389
Countries citing papers authored by Y.H. Park
This map shows the geographic impact of Y.H. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y.H. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y.H. Park more than expected).
Fields of papers citing papers by Y.H. Park
This network shows the impact of papers produced by Y.H. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y.H. Park. The network helps show where Y.H. Park may publish in the future.
Co-authors
The 25 scholars most cited alongside Y.H. Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study Hit paper breakdown → | 2020 | 279 |
| 2 | 2018 | 111 | |
| 3 | 2021 | 83 | |
| 4 | 2019 | 80 | |
| 5 | 2021 | 73 | |
| 6 | 2023 | 67 | |
| 7 | 2019 | 57 | |
| 8 | 2023 | 50 | |
| 9 | Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 Hit paper breakdown → | 2024 | 47 |
| 10 | 2019 | 41 | |
| 11 | 2020 | 36 | |
| 12 | 2013 | 35 | |
| 13 | 2023 | 28 | |
| 14 | 2023 | 25 | |
| 15 | 2023 | 24 | |
| 16 | 2019 | 23 | |
| 17 | 2021 | 22 | |
| 18 | 2024 | 21 | |
| 19 | 2022 | 21 | |
| 20 | 2023 | 20 |
About Y.H. Park
Y.H. Park is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Organic Chemistry and Radiology, Nuclear Medicine and Imaging, having authored 62 papers that have together received 1.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (25 papers), Cancer Treatment and Pharmacology (24 papers), Advanced Breast Cancer Therapies (23 papers), Breast Cancer Treatment Studies (16 papers), Cancer Immunotherapy and Biomarkers (10 papers), PARP inhibition in cancer therapy (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Brain Metastases and Treatment (5 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (295 citations), Immunology (253 citations), Reproductive Medicine (101 citations) and Pulmonary and Respiratory Medicine (389 citations). Y.H. Park has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Javier Cortés, Rebecca Dent, Vassiliki Karantza, Konstantinos Tryfonidis, Joohyuk Sohn, Theodoros Foukakis, Sherko Küemmel, Peter Schmid, Sherene Loi and Seock‐Ah Im. Their work appears in journals such as Annals of Oncology, ESMO Open, Journal of the American Chemical Society, Angewandte Chemie International Edition and Laryngoscope Investigative Otolaryngology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.